ArticleFrontiers in pharmacology2024

Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma.

Juanyan Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.